REPORTS

Let’s Pullulate and Expand Your Business

Global Opioid Induced Constipation (OIC) Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 15, 2020  |  177 PAGES  |  REPORT CODE: CMM371263
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Opioid Induced Constipation (OIC) Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period. The research provides insights for the global Opioid Induced Constipation (OIC) Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Opioid Induced Constipation (OIC) Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Opioid Induced Constipation (OIC) Drug Market Segmentations:

By Players:

  • Ironwood Pharmaceuticals

  • Daiichi Sankyo Co

  • Pfizer

  • Progenics Pharmaceuticals

  • Shionogi &

  • Allergan

  • Nektar Therapeutics

  • Purdue Pharma

  • SLA Pharma

  • Mundipharma International Limited

  • Ono Pharmaceutical

  • Takeda Pharmaceutical Company Limited

  • Theravance Biopharma

  • Valeant Pharmaceuticals International

  • Cosmo Pharmaceuticals SA

  • Daewoong Pharmaceutical

  • CB Fleet Company

  • Sucampo Pharmaceuticals

By Types:

  • Lubiprostone

  • Methyl Naltrexone Bromide

  • Naldemedine

  • Alvimopan

  • Other

By End-User:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation (OIC) Drug Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • 1.3.2 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

    • 1.3.3 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Naldemedine from 2014 to 2026

    • 1.3.4 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Alvimopan from 2014 to 2026

    • 1.3.5 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Other from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Opioid Induced Constipation (OIC) Drug Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Opioid Induced Constipation (OIC) Drug by Major Types

    • 3.4.1 Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Lubiprostone

    • 3.4.2 Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Methyl Naltrexone Bromide

    • 3.4.3 Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Naldemedine

    • 3.4.4 Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Alvimopan

    • 3.4.5 Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Other

4 Segmentation of Opioid Induced Constipation (OIC) Drug Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Opioid Induced Constipation (OIC) Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drug in Hospital Pharmacies

    • 4.4.2 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drug in Retail Pharmacies

    • 4.4.3 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drug in Online Pharmacies

5 Market Analysis by Major Regions

  • 5.1 Global Opioid Induced Constipation (OIC) Drug Production Analysis by Major Regions

  • 5.2 Global Opioid Induced Constipation (OIC) Drug Consumption Analysis by Major Regions

  • 5.3 Global Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

6 Product Commodity of Opioid Induced Constipation (OIC) Drug Market in Major Countries

  • 6.1 Top 5 Export Countries in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Opioid Induced Constipation (OIC) Drug Landscape Analysis

  • 7.1 North America Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Types

  • 7.2 North America Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major End-Users

  • 7.3 North America Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Countries

    • 7.3.1 United States Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 7.3.2 Canada Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 7.3.3 Mexico Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

8 Europe Opioid Induced Constipation (OIC) Drug Landscape Analysis

  • 8.1 Europe Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Types

  • 8.2 Europe Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major End-Users

  • 8.3 Europe Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Countries

    • 8.3.1 Germany Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.2 UK Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.3 France Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.4 Italy Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.6 Spain Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.7 Belgium Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.8 Poland Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.9 Russia Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 8.3.10 Turkey Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

9 Asia Pacific Opioid Induced Constipation (OIC) Drug Landscape Analysis

  • 9.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Types

  • 9.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Countries

    • 9.3.1 China Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 9.3.2 Japan Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 9.3.4 India Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 9.3.6 South Korea Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

10 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 10.3.2 Brazil Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 10.3.3 Nigeria Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

    • 10.3.4 South Africa Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate 

    • 10.3.5 Argentina Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Ironwood Pharmaceuticals

    • 11.1.1 Ironwood Pharmaceuticals Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Daiichi Sankyo Co

    • 11.2.1 Daiichi Sankyo Co Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Pfizer

    • 11.3.1 Pfizer Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Progenics Pharmaceuticals

    • 11.4.1 Progenics Pharmaceuticals Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Shionogi &

    • 11.5.1 Shionogi & Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Allergan

    • 11.6.1 Allergan Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Nektar Therapeutics

    • 11.7.1 Nektar Therapeutics Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Purdue Pharma

    • 11.8.1 Purdue Pharma Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 SLA Pharma

    • 11.9.1 SLA Pharma Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Mundipharma International Limited

    • 11.10.1 Mundipharma International Limited Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Ono Pharmaceutical

    • 11.11.1 Ono Pharmaceutical Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Takeda Pharmaceutical Company Limited

    • 11.12.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Theravance Biopharma

    • 11.13.1 Theravance Biopharma Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Valeant Pharmaceuticals International

    • 11.14.1 Valeant Pharmaceuticals International Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Cosmo Pharmaceuticals SA

    • 11.15.1 Cosmo Pharmaceuticals SA Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Daewoong Pharmaceutical

    • 11.16.1 Daewoong Pharmaceutical Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 CB Fleet Company

    • 11.17.1 CB Fleet Company Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Sucampo Pharmaceuticals

    • 11.18.1 Sucampo Pharmaceuticals Company Profile and Recent Development

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 97 Figures and 207 Tables)

  • Figure Product Picture

  • Figure Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Lubiprostone from 2014 to 2026

  • Figure Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

  • Figure Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Naldemedine from 2014 to 2026

  • Figure Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Alvimopan from 2014 to 2026

  • Figure Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Other from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

  • Figure Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

  • Figure Global Opioid Induced Constipation (OIC) Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Opioid Induced Constipation (OIC) Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation (OIC) Drug Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Opioid Induced Constipation (OIC) Drug

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Opioid Induced Constipation (OIC) Drug by Different Types from 2014 to 2026

  • Table Consumption Share of Opioid Induced Constipation (OIC) Drug by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Lubiprostone

  • Figure Market Size and Growth Rate of Methyl Naltrexone Bromide

  • Figure Market Size and Growth Rate of Naldemedine

  • Figure Market Size and Growth Rate of Alvimopan

  • Figure Market Size and Growth Rate of Other

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Opioid Induced Constipation (OIC) Drug by Different End-Users from 2014 to 2026

  • Table Consumption Share of Opioid Induced Constipation (OIC) Drug by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital Pharmacies

  • Figure Market Size and Growth Rate of Retail Pharmacies

  • Figure Market Size and Growth Rate of Online Pharmacies

  • Table Global Opioid Induced Constipation (OIC) Drug Production by Major Regions

  • Table Global Opioid Induced Constipation (OIC) Drug Production Share by Major Regions

  • Figure Global Opioid Induced Constipation (OIC) Drug Production Share by Major Regions in 2014

  • Figure Global Opioid Induced Constipation (OIC) Drug Production Share by Major Regions in 2018

  • Figure Global Opioid Induced Constipation (OIC) Drug Production Share by Major Regions in 2026

  • Table Global Opioid Induced Constipation (OIC) Drug Consumption by Major Regions

  • Table Global Opioid Induced Constipation (OIC) Drug Consumption Share by Major Regions

  • Figure Global Opioid Induced Constipation (OIC) Drug Consumption Share by Major Regions in 2014

  • Figure Global Opioid Induced Constipation (OIC) Drug Consumption Share by Major Regions in 2018

  • Figure Global Opioid Induced Constipation (OIC) Drug Consumption Share by Major Regions in 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

  • Table Europe Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation (OIC) Drug market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption by Types from 2014 to 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption Share by Types from 2014 to 2026

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2014

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2018

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption by End-Users from 2014 to 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users from 2014 to 2026

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2014

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2018

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption by Major Countries from 2014 to 2026

  • Table North America Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2014

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2018

  • Figure North America Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2026

  • Figure United States Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption by Types from 2014 to 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Types from 2014 to 2026

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2014

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2018

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption by End-Users from 2014 to 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2014

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2018

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption by Major Countries from 2014 to 2026

  • Table Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2014

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2018

  • Figure Europe Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2026

  • Figure Germany Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure France Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption by Types from 2014 to 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2014

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2018

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2014

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2018

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2026

  • Figure China Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandOpioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure India Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Opioid Induced Constipation (OIC) Drug Consumption Share by Major Countries in 2026

  • Figure GCC Countries Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Opioid Induced Constipation (OIC) Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Ironwood Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals

  • Table Product and Service Introduction of Ironwood Pharmaceuticals

  • Table Company Profile and Development Status of Daiichi Sankyo Co

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co

  • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co

  • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co

  • Table Product and Service Introduction of Daiichi Sankyo Co

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Progenics Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

  • Table Product and Service Introduction of Progenics Pharmaceuticals

  • Table Company Profile and Development Status of Shionogi &

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi &

  • Figure Sales and Growth Rate Analysis of Shionogi &

  • Figure Revenue and Market Share Analysis of Shionogi &

  • Table Product and Service Introduction of Shionogi &

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of Nektar Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

  • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

  • Figure Revenue and Market Share Analysis of Nektar Therapeutics

  • Table Product and Service Introduction of Nektar Therapeutics

  • Table Company Profile and Development Status of Purdue Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

  • Figure Sales and Growth Rate Analysis of Purdue Pharma

  • Figure Revenue and Market Share Analysis of Purdue Pharma

  • Table Product and Service Introduction of Purdue Pharma

  • Table Company Profile and Development Status of SLA Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SLA Pharma

  • Figure Sales and Growth Rate Analysis of SLA Pharma

  • Figure Revenue and Market Share Analysis of SLA Pharma

  • Table Product and Service Introduction of SLA Pharma

  • Table Company Profile and Development Status of Mundipharma International Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma International Limited

  • Figure Sales and Growth Rate Analysis of Mundipharma International Limited

  • Figure Revenue and Market Share Analysis of Mundipharma International Limited

  • Table Product and Service Introduction of Mundipharma International Limited

  • Table Company Profile and Development Status of Ono Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical

  • Figure Revenue and Market Share Analysis of Ono Pharmaceutical

  • Table Product and Service Introduction of Ono Pharmaceutical

  • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

  • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

  • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

  • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

  • Table Company Profile and Development Status of Theravance Biopharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance Biopharma

  • Figure Sales and Growth Rate Analysis of Theravance Biopharma

  • Figure Revenue and Market Share Analysis of Theravance Biopharma

  • Table Product and Service Introduction of Theravance Biopharma

  • Table Company Profile and Development Status of Valeant Pharmaceuticals International

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

  • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

  • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

  • Table Product and Service Introduction of Valeant Pharmaceuticals International

  • Table Company Profile and Development Status of Cosmo Pharmaceuticals SA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals SA

  • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals SA

  • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals SA

  • Table Product and Service Introduction of Cosmo Pharmaceuticals SA

  • Table Company Profile and Development Status of Daewoong Pharmaceutical

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical

  • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical

  • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical

  • Table Product and Service Introduction of Daewoong Pharmaceutical

  • Table Company Profile and Development Status of CB Fleet Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CB Fleet Company

  • Figure Sales and Growth Rate Analysis of CB Fleet Company

  • Figure Revenue and Market Share Analysis of CB Fleet Company

  • Table Product and Service Introduction of CB Fleet Company

  • Table Company Profile and Development Status of Sucampo Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

  • Table Product and Service Introduction of Sucampo Pharmaceuticals


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top